Epothilones
Showing 1 - 25 of 75
CIPN and it's Impact on Quality of Life in Patients Receiving
Not yet recruiting
- Chemotherapy-induced Peripheral Neuropathy
- (no location specified)
Apr 24, 2023
SCLC, Extensive Stage Trial in Zhengzhou (Utidelone, Placebo)
Recruiting
- SCLC, Extensive Stage
- Utidelone
- Placebo
-
Zhengzhou, Henan, ChinaHenan Tumor Hospital
Mar 24, 2022
Bilateral Breast Carcinoma, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Oak Lawn, Houston (Best Practice, Ixabepilone)
Active, not recruiting
- Bilateral Breast Carcinoma
- +2 more
- Best Practice
- Ixabepilone
-
Oak Lawn, Illinois
- +2 more
Mar 10, 2022
Chemo Induced Peripheral Neuropathy (CIPN) Trial (Stibium metallicum praeparatum 6x, Placebo)
Not yet recruiting
- Chemotherapy Induced Peripheral Neuropathy (CIPN)
- Stibium metallicum praeparatum 6x
- Placebo
- (no location specified)
Jan 21, 2022
Solid Tumors Trial in Houston (Patupilone and Omeprazole, Patupilone + Midalzolam)
Completed
- Solid Tumors
- Patupilone and Omeprazole
- Patupilone + Midalzolam
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Dec 6, 2020
International CIPN Assessment and Validation Study
Recruiting
- Chemotherapy-induced Peripheral Neuropathy
- Quality of Life
- outcome measures for CIPN testing
-
Birmingham, Alabama
- +29 more
Apr 27, 2022
Solid Tumors Trial in New York (Iso-Fludelone)
Active, not recruiting
- Solid Tumors
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 7, 2021
Standard Anti-microtubule Drugs as Assessed by Early Tumor
Recruiting
- Breast Cancer
- Breast Neoplasms
- Taxane
- +4 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Dec 10, 2021
Cervical Carcinoma, Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma Trial run by the NCI (Ixempra (Ixabepilone
Terminated
- Cervical Carcinoma
- +3 more
- Ixempra (Ixabepilone (BMS-247550) )
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 13, 2019
Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Tumors Trial in Worldwide (EPO906 (Patupilone), doxorubicin)
Completed
- Ovarian Cancer
- +2 more
- EPO906 (Patupilone)
- doxorubicin
-
Anchorage, Alaska
- +148 more
Dec 11, 2020
Non Small Cell Lung Cancer Trial in Italy, United States (Ixabepilone, Cisplatin)
Completed
- Non Small Cell Lung Cancer
-
Washington, District of Columbia
- +6 more
Oct 6, 2020
Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma Trial in United States
Active, not recruiting
- Endometrial Adenocarcinoma
- +9 more
- Bevacizumab
- +5 more
-
Phoenix, Arizona
- +232 more
Jan 12, 2023
Breast Cancer, Metastases Trial in Worldwide (Ixabepilone + Capecitabine, Capecitabine)
Completed
- Breast Cancer
- Metastases
- Ixabepilone + Capecitabine
- Capecitabine
-
Little Rock, Arkansas
- +126 more
Oct 6, 2020
Cancer, Breast Cancer Trial in Worldwide (Ixabepilone + Capecitabine, Capecitabine)
Completed
- Cancer
- Breast Cancer
- Ixabepilone + Capecitabine
- Capecitabine
-
Tucson, Arizona
- +188 more
Oct 6, 2020
Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer Trial in Philadelphia (ixabepilone)
Completed
- Primary Peritoneal Cavity Cancer
- Recurrent Ovarian Epithelial Cancer
-
Philadelphia, PennsylvaniaGynecologic Oncology Group
Jul 22, 2019
Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma Trial in United States (Ixabepilone, Laboratory Biomarker
Completed
- Recurrent Uterine Corpus Sarcoma
- Uterine Corpus Leiomyosarcoma
- Ixabepilone
- Laboratory Biomarker Analysis
-
Phoenix, Arizona
- +71 more
Aug 6, 2019
Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma Trial in United States (Ixabepilone, Laboratory Biomarker Analysis)
Completed
- Recurrent Uterine Corpus Sarcoma
- Uterine Carcinosarcoma
- Ixabepilone
- Laboratory Biomarker Analysis
-
Little Rock, Arkansas
- +77 more
Aug 6, 2019
CNS Tumors, Head and Neck Tumors Trial in Philadelphia (EPO906 (epothilone B))
Completed
- Central Nervous System Neoplasms
- Head and Neck Neoplasms
- EPO906 (epothilone B)
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Jul 13, 2018
Medical Oncology Trial in United Kingdom, United States (BAY1143269 tablet)
Terminated
- Medical Oncology
- BAY1143269 tablet
-
Dallas, Texas
- +3 more
Mar 6, 2018
Prostatic Diseases, Genital Tumors, Male, Urogenital Tumors Trial in Los Angeles (Ixabepilone)
Terminated
- Prostatic Diseases
- +7 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Oct 22, 2018
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in San Francisco, Madison
Completed
- Adenocarcinoma of the Prostate
- +2 more
- mitoxantrone hydrochloride
- +2 more
-
San Francisco, California
- +1 more
Oct 2, 2017